These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

869 related articles for article (PubMed ID: 1700053)

  • 1. Immunogenicity and tolerogenicity of self-major histocompatibility complex peptides.
    Benichou G; Takizawa PA; Ho PT; Killion CC; Olson CA; McMillan M; Sercarz EE
    J Exp Med; 1990 Nov; 172(5):1341-6. PubMed ID: 1700053
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Presentation of a self-peptide for in vivo tolerance induction of CD4+ T cells is governed by a processing factor that maps to the class II region of the major histocompatibility complex locus.
    Fedoseyeva EV; Tam RC; Orr PL; Garovoy MR; Benichou G
    J Exp Med; 1995 Nov; 182(5):1481-91. PubMed ID: 7595218
    [TBL] [Abstract][Full Text] [Related]  

  • 3. T cells that recognize peptide sequences of self MHC class II molecules exist in syngeneic mice.
    Agrawal B; Manickasundari M; Fraga E; Singh B
    J Immunol; 1991 Jul; 147(2):383-90. PubMed ID: 1649218
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Self major histocompatibility complex class I antigens expressed solely in lymphoid cells do not induce tolerance in the CD4+ T cell compartment.
    Schulz R; Mellor AL
    J Exp Med; 1996 Oct; 184(4):1573-8. PubMed ID: 8879232
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Unresponsiveness to a self-peptide of mouse lysozyme owing to hindrance of T cell receptor-major histocompatibility complex/peptide interaction caused by flanking epitopic residues.
    Moudgil KD; Grewal IS; Jensen PE; Sercarz EE
    J Exp Med; 1996 Feb; 183(2):535-46. PubMed ID: 8627165
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Exploring the MHC-peptide matrix of central tolerance in the human thymus.
    Adamopoulou E; Tenzer S; Hillen N; Klug P; Rota IA; Tietz S; Gebhardt M; Stevanovic S; Schild H; Tolosa E; Melms A; Stoeckle C
    Nat Commun; 2013; 4():2039. PubMed ID: 23783831
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MHC class II molecules bind indiscriminately self and non-self peptide homologs: effect on the immunogenicity of non-self peptides.
    Sette A; Sidney J; Gaeta FC; Appella E; Colón SM; del Guercio MF; Guéry JC; Adorini L
    Int Immunol; 1993 Jun; 5(6):631-8. PubMed ID: 8347557
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immune responses to self peptides naturally presented by murine class II major histocompatibility complex molecules.
    Rider BJ; Fraga E; Yu Q; Singh B
    Mol Immunol; 1996; 33(7-8):625-33. PubMed ID: 8760274
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mechanisms of acquired thymic unresponsiveness to renal allografts. Thymic recognition of immunodominant allo-MHC peptides induces peripheral T cell anergy.
    Sayegh MH; Perico N; Gallon L; Imberti O; Hancock WW; Remuzzi G; Carpenter CB
    Transplantation; 1994 Jul; 58(2):125-32. PubMed ID: 8042230
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Analysis of peptide binding patterns in different major histocompatibility complex/T cell receptor complexes using pigeon cytochrome c-specific T cell hybridomas. Evidence that a single peptide binds major histocompatibility complex in different conformations.
    Bhayani H; Paterson Y
    J Exp Med; 1989 Nov; 170(5):1609-25. PubMed ID: 2553848
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Induction of central T cell tolerance: recombinant antibodies deliver peptides for deletion of antigen-specific (CD4+)8+ thymocytes.
    Schjetne KW; Thommesen JE; Fredriksen AB; Lunde E; Sandlie I; Bogen B
    Eur J Immunol; 2005 Nov; 35(11):3142-52. PubMed ID: 16184515
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Distinction between immunogenicity and tolerogenicity among HBcAg T cell determinants. Influence of peptide-MHC interaction.
    Milich DR; Jones JE; McLachlan A; Houghten R; Thornton GB; Hughes JL
    J Immunol; 1989 Nov; 143(10):3148-56. PubMed ID: 2478619
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Functional and phenotypic evidence for presentation of E alpha 52-68 structurally related self-peptide(s) in I-E alpha-deficient mice.
    Viret C; Janeway CA
    J Immunol; 2000 May; 164(9):4627-34. PubMed ID: 10779766
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Functional consequences of the binding of MHC class II-derived peptides to MHC class II.
    Feili-Hariri M; Kao H; Mietzner TA; Morel PA
    Int Immunol; 1996 Dec; 8(12):1857-65. PubMed ID: 8982770
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Peptide vaccines incorporating a 'promiscuous' T-cell epitope bypass certain haplotype restricted immune responses and provide broad spectrum immunogenicity.
    Kaumaya PT; Kobs-Conrad S; Seo YH; Lee H; VanBuskirk AM; Feng N; Sheridan JF; Stevens V
    J Mol Recognit; 1993 Jun; 6(2):81-94. PubMed ID: 7508238
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Peptide presentation by class-I major histocompatibility complex molecules.
    Nikolić-Zugić J; Carbone FR
    Immunol Res; 1991; 10(1):54-65. PubMed ID: 1865131
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Disruption of the determinant hierarchy on a self-MHC peptide: concomitant tolerance induction to the dominant determinant and priming to the cryptic self-determinant.
    Benichou G; Fedoseyeva E; Olson CA; Geysen HM; McMillan M; Sercarz EE
    Int Immunol; 1994 Jan; 6(1):131-8. PubMed ID: 7511927
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Constitutive presentation of dominant epitopes from endogenous naturally processed self-beta 2-microglobulin to class II-restricted T cells leads to self-tolerance.
    Guéry JC; Sette A; Appella E; Adorini L
    J Immunol; 1995 Jan; 154(2):545-54. PubMed ID: 7814867
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Class II major histocompatibility complex mutant mice to study the germ-line bias of T-cell antigen receptors.
    Silberman D; Krovi SH; Tuttle KD; Crooks J; Reisdorph R; White J; Gross J; Matsuda JL; Gapin L; Marrack P; Kappler JW
    Proc Natl Acad Sci U S A; 2016 Sep; 113(38):E5608-17. PubMed ID: 27588903
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Transient T and B cell activation after neonatal induction of tolerance to MHC class II or Mls alloantigens.
    Schurmans S; Brighouse G; Kramer G; Wen L; Izui S; Merino J; Lambert PH
    J Immunol; 1991 Apr; 146(7):2152-60. PubMed ID: 1672344
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 44.